Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2010
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2010
Report date:
2010

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
Qualifier:
according to guideline
Guideline:
EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
GLP compliance:
yes (incl. QA statement)
Type of study:
mouse local lymph node assay (LLNA)

Test material

1
Chemical structure
Reference substance name:
4-benzyloxyaniline hydrochloride
EC Number:
257-170-6
EC Name:
4-benzyloxyaniline hydrochloride
Cas Number:
51388-20-6
Molecular formula:
C13H13NO.ClH
IUPAC Name:
4-benzyloxyaniline hydrochloride
Test material form:
solid

In vivo test system

Test animals

Species:
mouse

Study design: in vivo (LLNA)

Vehicle:
dimethyl sulphoxide
Concentration:
Test item concentrations of 2.5, 5, and 10% (w/v).

Results and discussion

In vivo (LLNA)

Resultsopen allclose all
Parameter:
SI
Remarks:
concentrations of 2.5% (w/v) in dimethylsulfoxide
Value:
6.91
Parameter:
SI
Remarks:
concentrations of 5% (w/v) in dimethylsulfoxide
Value:
9.21
Parameter:
SI
Remarks:
concentrations of 10% (w/v) in dimethylsulfoxide
Value:
8.62
Test group / Remarks:
The S.I. for the high dose group was derived from 3 animals only due to the fact that two animals belonging to this group died during the course of the study.

Any other information on results incl. tables

In the groups treated with 2.5 and 5% test item concentration, the animals did not show any clinical signs during the course of the study and no cases of mortality were observed.

In the group treated with 10% test item concentration, two animals (animal no. 16 and 20) were found dead on study day 5. Signs of local skin irritation were not observed in any group during the study period.

Applicant's summary and conclusion

Interpretation of results:
Category 1 (skin sensitising) based on GHS criteria
Conclusions:
The test item BOA.HCI was found to be a skin sensitiser under the described conditions. In view of these results, according to the Regulation (EC) No. 1272/2008 on classification, labeling and packaging (CLP) of substances and mixtures, the test item is classified as "skin sensitiser category 1, H317 (“May cause an allergic skin reaction”)". According to the former European Dangerous Substance Directive (Council Directive 67/548/EEC, currently undergoing a phase-out process), the test item is classified as sensitizing and assigned the symbol “Xi”, the indication of danger “Irritant” and the risk phrase R43 ("may cause sensitisation by skin contact”).